{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:45:38Z","timestamp":1791963938665,"version":"4.3.4"},"reference-count":34,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The importance of the stromal microenvironment in chronic lymphocytic leukemia (CLL) pathogenesis and drug resistance is well established. Despite recent advances in CLL therapy, identifying novel ways to disrupt interactions between CLL and its microenvironment may identify new combination partners for the drugs currently in use. To understand the role of microenvironmental factors on primary CLL cells, we took advantage of an observation that conditioned media (CM) collected from stroma was protective of CLL cells from spontaneous cell death ex\u00a0vivo. The cytokine in the CM-dependent cells that most supports CLL survival in short-term ex\u00a0vivo culture was CCL2. Pretreatment of CLL cells with anti-CCL2 antibody enhanced venetoclax-mediated killing. Surprisingly, we found a group of CLL samples (9\/23 cases) that are less likely to undergo cell death in the absence of CM support. Functional studies revealed that CM-independent (CMI) CLL cells are less sensitive to apoptosis than conventional stroma-dependent CLL. In addition, a majority of the CMI CLL samples (80%) harbored unmutated immunoglobulin heavy-chain variable (IGHV) region. Bulk-RNA sequence analysis revealed upregulation of the focal adhesion and RAS signaling pathways in this group, along with expression of fms-like tyrosine kinase 3 (FLT3) and CD135. Treatment with FLT3 inhibitors caused a significant reduction in cell viability among CMI samples. In summary, we were able to discriminate and target 2 biologically distinct subgroups of CLL based on CM dependence with distinct microenvironmental vulnerabilities.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022008207","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T18:29:31Z","timestamp":1689013771000},"page":"5877-5889","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Targeting conditioned media dependencies and FLT-3 in chronic lymphocytic leukemia"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6111-1212","authenticated-orcid":false,"given":"Salma","family":"Parvin","sequence":"first","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Aryal","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9116-5238","authenticated-orcid":false,"given":"Shanye","family":"Yin","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"},{"name":"2Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey G.","family":"Fell","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Davids","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3348-5054","authenticated-orcid":false,"given":"Catherine J.","family":"Wu","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"},{"name":"2Harvard Medical School, Boston, MA"},{"name":"3Broad Institute of MIT and Harvard, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Letai","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"},{"name":"2Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"issue":"17","key":"2023101012113244100_bib1","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1182\/blood-2012-02-414060","article-title":"Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia","volume":"120","author":"Davids","year":"2012","journal-title":"Blood"},{"issue":"18","key":"2023101012113244100_bib2","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1182\/blood-2008-08-173310","article-title":"Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia","volume":"113","author":"Vogler","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2023101012113244100_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2141.1996.00305.x","article-title":"Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in\u00a0vitro","volume":"92","author":"Panayiotidis","year":"1996","journal-title":"Br J Haematol"},{"issue":"7","key":"2023101012113244100_bib34","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1515\/hsz-2016-0107","article-title":"iBH3: simple, fixable BH3 profiling to determine apoptotic priming in primary tissue by flow cytometry","volume":"397","author":"Ryan","year":"2016","journal-title":"Biol Chem"},{"issue":"1","key":"2023101012113244100_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"12","key":"2023101012113244100_bib5","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"1","key":"2023101012113244100_bib6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12859-018-2139-9","article-title":"VIPER: visualization pipeline for RNA-seq, a Snakemake workflow for efficient and complete RNA-seq analysis","volume":"19","author":"Cornwell","year":"2018","journal-title":"BMC Bioinformatics"},{"issue":"8","key":"2023101012113244100_bib7","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","article-title":"Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1","volume":"96","author":"Burger","year":"2000","journal-title":"Blood"},{"issue":"20","key":"2023101012113244100_bib8","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood.2022016040","article-title":"Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapy","volume":"140","author":"Thijssen","year":"2022","journal-title":"Blood"},{"issue":"4","key":"2023101012113244100_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccell.2019.08.005","article-title":"Mitochondrial reprogramming underlies resistance to BCL-2 inhibition in lymphoid malignancies","volume":"36","author":"Guieze","year":"2019","journal-title":"Cancer Cell"},{"issue":"5","key":"2023101012113244100_bib10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ccr.2006.03.027","article-title":"Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members","volume":"9","author":"Certo","year":"2006","journal-title":"Cancer Cell"},{"issue":"10","key":"2023101012113244100_bib11","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.3109\/10428194.2012.672735","article-title":"CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in\u00a0vitro","volume":"53","author":"Burgess","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"25","key":"2023101012113244100_bib12","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1182\/blood-2016-01-688796","article-title":"The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism","volume":"127","author":"Anderson","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2023101012113244100_bib13","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1182\/blood.V99.3.1030","article-title":"Distinctive features of \"nurselike\" cells that differentiate in the context of chronic lymphocytic leukemia","volume":"99","author":"Tsukada","year":"2002","journal-title":"Blood"},{"issue":"3","key":"2023101012113244100_bib14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3324\/haematol.2010.031377","article-title":"Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in\u00a0vitro: a dominant role of CCL2","volume":"96","author":"Schulz","year":"2011","journal-title":"Haematologica"},{"issue":"5","key":"2023101012113244100_bib15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1034\/j.1600-0609.2003.00063.x","article-title":"The antiapoptotic effects of blood constituents in patients with chronic lymphocytic leukemia","volume":"70","author":"Bomstein","year":"2003","journal-title":"Eur J Haematol"},{"issue":"2","key":"2023101012113244100_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2007.05.013","article-title":"Role of chemokines in tumor growth","volume":"256","author":"Raman","year":"2007","journal-title":"Cancer Lett"},{"issue":"11","key":"2023101012113244100_bib17","doi-asserted-by":"crossref","first-page":"7352","DOI":"10.4049\/jimmunol.179.11.7352","article-title":"CCL2 inhibits the apoptosis program induced by growth factor deprivation, rescuing functional T cells","volume":"179","author":"Diaz-Guerra","year":"2007","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"2023101012113244100_bib18","doi-asserted-by":"crossref","first-page":"e2012055","DOI":"10.4084\/mjhid.2012.055","article-title":"Toll-like receptors in chronic lymphocytic leukemia","volume":"4","author":"Muzio","year":"2012","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"3","key":"2023101012113244100_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.semcancer.2003.10.009","article-title":"CCL2 (monocyte chemoattractant protein-1) and cancer","volume":"14","author":"Conti","year":"2004","journal-title":"Semin Cancer Biol"},{"issue":"5-6","key":"2023101012113244100_bib20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/10428199909169609","article-title":"Adhesion to bone marrow stroma inhibits apoptosis of chronic lymphocytic leukemia cells","volume":"35","author":"Lagneaux","year":"1999","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"2023101012113244100_bib21","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1182\/blood.2019004205","article-title":"Multiple BCL2 mutations cooccurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax","volume":"135","author":"Blombery","year":"2020","journal-title":"Blood"},{"issue":"2","key":"2023101012113244100_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1182\/blood.2018882555","article-title":"Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables","volume":"134","author":"Roberts","year":"2019","journal-title":"Blood"},{"issue":"10","key":"2023101012113244100_bib23","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1182\/blood.2019004767","article-title":"Breaking through BCL-2 inhibition in CLL","volume":"135","author":"Chong","year":"2020","journal-title":"Blood"},{"issue":"3","key":"2023101012113244100_bib24","first-page":"119","article-title":"Impact of the anti-inflammatory agent bindarit on the chemokinome: selective inhibition of the monocyte chemotactic proteins","volume":"19","author":"Mirolo","year":"2008","journal-title":"Eur Cytokine Netw"},{"issue":"6","key":"2023101012113244100_bib25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10585-012-9473-5","article-title":"Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models","volume":"29","author":"Zollo","year":"2012","journal-title":"Clin Exp Metastasis"},{"issue":"4","key":"2023101012113244100_bib26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000330685","article-title":"Antiproteinuric effect of chemokine C-C motif ligand 2 inhibition in subjects with acute proliferative lupus nephritis","volume":"34","author":"Ble","year":"2011","journal-title":"Am J Nephrol"},{"issue":"4","key":"2023101012113244100_bib27","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00280-013-2099-8","article-title":"A\u00a0first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors","volume":"71","author":"Sandhu","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"issue":"12","key":"2023101012113244100_bib28","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.it.2013.07.002","article-title":"B\u00a0cell receptor signaling in chronic lymphocytic leukemia","volume":"34","author":"Burger","year":"2013","journal-title":"Trends Immunol"},{"issue":"5","key":"2023101012113244100_bib29","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1634\/stemcells.2005-0519","article-title":"FMS-like tyrosine kinase 3 in normal hematopoiesis and acute myeloid leukemia","volume":"24","author":"Parcells","year":"2006","journal-title":"Stem Cells"},{"issue":"4","key":"2023101012113244100_bib30","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/ni.2255","article-title":"The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential","volume":"13","author":"Luc","year":"2012","journal-title":"Nat Immunol"},{"issue":"48","key":"2023101012113244100_bib31","doi-asserted-by":"crossref","first-page":"E6644","DOI":"10.1073\/pnas.1514191112","article-title":"Murine germinal center B cells require functional fms-like tyrosine kinase 3 signaling for IgG1 class-switch recombination","volume":"112","author":"Svensson","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2023101012113244100_bib32","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood.V87.3.1089.bloodjournal8731089","article-title":"Expression of the hematopoietic growth factor receptor FLT3 (STK-UFIk2) in human leukemias","volume":"87","author":"Catherine","year":"1996","journal-title":"Blood"},{"issue":"2","key":"2023101012113244100_bib33","doi-asserted-by":"crossref","first-page":"1000113","DOI":"10.4172\/2329-6917.1000113","article-title":"Stromal tumor microenvironment in chronic lymphocytic leukemia: regulation of leukemic progression","volume":"1","author":"Shukla","year":"2013","journal-title":"J Leuk"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/19\/5877\/2083765\/blooda_adv-2022-008207-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/19\/5877\/2083765\/blooda_adv-2022-008207-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T12:12:11Z","timestamp":1696939931000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/19\/5877\/496798\/Targeting-conditioned-media-dependencies-and-FLT-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":34,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2023,10,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022008207","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,29]]}}}